Pricing

Edgewise Therapeutics Inc (EWTX)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
CEO: Kevin Koch
Employees: 60
Web site: edgewisetx.com
1715 38TH ST, BOULDER, CO, 80301
720-262-7002
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available